Updated Oct 27, 2026 · 09:24 UTC
AMGNAmgen
Health Care · United States · XNAS · biological products, (no diagnostic substances)
$443.25+1.22%last session · market early-hours
Market cap
$239.64b
real-world
Tokenized
$8k
<0.001% of the asset
Avg token price
$449.96
+1.51% vs real
Spot volume, 24h
$312k
4 venues
Derivatives, 24h
$3.3m
0.4% of real volume
Perp open interest
$1.1m
9 venues
In DeFi
—
AMGN · Price
Token Real
EarningsNasdaq’s earnings calendar
Next earnings
Nov 3
after the close · Sep 2026 quarter · EPS forecast $5.74 (9 analysts)
Last earnings, Aug 4
$6.29 EPS
+12.3% vs $5.60 forecast · Jun 2026 quarter
Real marketAmgen Inc
Last close
$439.26
Oct 23
Traded on Oct 23
$915.0m
Price now
$443.25
market early-hours
Where it trades24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · $312k · 4 venues
Blynex1 pair$160k
MEXC1 pair$152k
Ondo Stocks1 pair$121Derivatives · $3.3m · 9 venues · $1.1m open interest
BingX1 pair · OI $966k · funding +0.0050%$1.2m
Bybit1 pair · OI $48k · funding +0.0000%$1.2m
Zoomex1 pair · OI $5k · funding +0.0000%$367kIn DeFiPools and lending markets that hold these tokens
None found
Onchain versions2 tokens from 2 issuers
AMGNonOndo Assets$450.06$8k
wAMGNxBacked Assets——HoldersAddresses holding its tokens on each chain counted, each token counted and added, issuers’ own addresses left out · the value is what they hold onchain
BNB Chain44 holders$888
Ethereum18 holders$4k
Solana9 holders$3kBusiness 12 months to Jun 2026 · SEC EDGAR
Results
Revenue
$38.09b
+9% YoY
Operating income
$11.43b
30% margin · +39% YoY
Net income
$8.74b
23% margin · +32% YoY
EPS, diluted
$16.07
+31% YoY
Diluted shares
544m
+1% YoY
Cash and balance sheet
Free cash flow
$10.18b
27% of revenue · 4.2% yield
Net debt
$43.31b
$13.99b cash and securities, $57.30b debt
Quarterly
RevenueNet income
Valuation today’s market cap $239.64b · enterprise value $282.95b
P/E
27.4×
EV / sales
7.4×
EV / op. income
24.8×